Veracyte | VCYT - Loan Capital


Veracyte reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Agenus USD 169.66M 146.06M Dec/2025
Agilent USD 3.05B 1000K Mar/2026
Arrowhead Research USD 1.23B 687.3M Mar/2026
Bruker USD 1.66B 189.6M Mar/2026
Heron Therapeutics USD 140.64M 975K Dec/2025
Illumina USD 1.49B 0 Mar/2026
Intrexon USD 0 198.67M Jun/2024
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
Laboratory Of America USD 5.9B 748.3M Mar/2026
Ligand Pharmaceuticals USD 446.19M 702K Dec/2025
Myriad Genetics USD 120.3M 400K Mar/2026
Rigel Pharmaceuticals USD 0 0 Sep/2024
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Siemens EUR 41.52B 1.31B Mar/2026
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Veracyte USD 0 0 Mar/2025
Waters USD 5.22B 3.81B Mar/2026